AGM advises Polybion on investment round with Blue Horizon
Department of Marketing and Communication. AGM Abogados
The Mexican company Polybion, specialising in next-generation premium materials inspired by nature and manufactured with biology, closes investment round led by Blue Horizon, advised in the legal process by AGM Abogados, raising EUR 4 million. The capital will be used to expand its facilities, enhance its research and development capabilities, and implement Celium in consumer goods.
Polybion has announced the finalisation of the first stage of its bacterial cellulose plant, the world’s first, and the successful closing of its Series A financing round, led by Swiss Impact Investor Blue Horizon. The company, based in Mexico and Spain and founded in 2015 by Mexican entrepreneurs, is creating the next generation of high-performance bioassembled materials by recycling agro-industrial food waste and using living organisms such as bacteria as a platform.
For the two brothers Alexis and Axel Gómez-Ortigoza, both co-founders of Polybion, this EUR 4 million investment represents a major step in Polybion’s mission to bring performance and new possibilities to 21st century materials designers and engineers. In addition, having Blue Horizon as a partner, sharing a common vision on accelerating sustainability and the circular economy, will allow them to scale new initiatives to build their brand and expand their network.
The M&A team of AGM, led by the Partner of the area Francisco Lacasa Lobera and the head of the area, Julio Menchaca Vite, with the support of the lawyer Félix Navas Mir, has advised the founders of Polybion in all the legal aspects of the financing round in Spain, in coordination with the legal advisors in Mexico, for the joint execution of the operation in that country.
Polybion cultivates next-generation premium materials designed with nature and made with biology. The company’s mission is to bring performance and possibilities to 21st century materials designers and engineers. Polybion uses waste as raw material and designs, produces and finishes its bio-assembled products under one roof to increase sustainability and drive the circular economy. Polybion’s first product, Celium®, is a high-performance leather substitute based on bacterial cellulose.
About Blue Horizon
Blue Horizon is accelerating the transition to a New Sustainable Food System that generates attractive returns for investors and the planet. The fund is a global pioneer in the Future of Food. As impact investors in niche sectors, Blue Horizon has shaped the alternative food and protein technology market. The fund invests at the intersection of biology, agriculture and technology with the goal of transforming the global food industry. Blue Horizon was founded by Roger Lienhard in 2016 and is based in Zurich. To date, the fund has raised over USD 850 million and invested in more than 60 companies. Its business model offers an attractive opportunity to invest in the evolution of the global food system by contributing to building a healthy and sustainable world.